688202 Shanghai Medicilon Inc.
- 34.95
- +3.06+9.60%
Shanghai Medicilon Inc. News
Medici: Medici: Progress announcement on the repurchase of the company\'s shares through centralized bidding
Medici: Medici: Progress announcement on the repurchase of the company\'s shares through centralized bidding
Shanghai Medicilon Inc.: Announcement of Reply to Information Disclosure Inquiry Letter on 2023 Annual Report Regulation.
Shanghai Medicilon Inc.: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Anli (Shanghai) Law Firm on the 2023 Annual General Meeting of Shareholders of Shanghai Medici Biomedical Co., Ltd.
Shanghai Medicilon Inc.: Notice on directors and senior management receiving a warning letter from the Shanghai Securities Regulatory Bureau
Shanghai Medicilon Inc.: 2023 Annual General Meeting of Shareholders Meeting Materials
Shanghai Medicilon Inc.: Announcement on preparation for asset impairment accrued for the first quarter of 2024
Medici: Report on the performance of the Audit Committee of the Board of Directors in 2023
Medici: Special Report by the Board of Directors on the Self-Inspection of the Independence of Independent Directors
Medici: Report on the performance of supervisory duties by the Audit Committee against Lixin Certified Public Accountants (Special General Partnership)
Medici: 2024 “Improve Quality, Increase Efficiency, and Reward” Action Plan
Medici: Announcement on the use of its own idle funds for cash management
Medici: Notice on Convening the 2023 Annual General Meeting of Shareholders
Medici: Articles of Association (Revised April 2024)
Medici: Rules of Procedure for the Board of Directors (Revised April 2024)
Medici: Notice on changing the company's registered capital, amending the “Articles of Association”, registering industrial and commercial changes, and revising and formulating part of the company's governance system
Medici: Announcement on Preparation for Impairment of Accrued Assets and Write-off of Assets for 2023
Medici: Lixin Certified Public Accountants (Special General Partnership) Special Report on the Company's 2023 Non-Operating Capital Occupation and Other Related Capital Transactions
Medici: 2023 Internal Control Evaluation Report
Analysis
Price Target
No Data
No Data